Articles published by Exelixis, Inc.
![](https://mms.businesswire.com/media/20240806336755/en/1679909/5/Exelixis_Logo_RGB_2023.jpg)
Exelixis Announces Second Quarter 2024 Financial Results and Provides Corporate Update
August 06, 2024
From Exelixis, Inc.
Via Business Wire
Tickers
EXEL
![](https://mms.businesswire.com/media/20240805262570/en/1937209/22/2023_Exelixis_Logo.jpg)
![](https://mms.businesswire.com/media/20240723468114/en/1679909/5/Exelixis_Logo_RGB_2023.jpg)
![](https://mms.businesswire.com/media/20240528802316/en/1679909/5/Exelixis_Logo_RGB_2023.jpg)
![](https://mms.businesswire.com/media/20240520945977/en/1937209/22/2023_Exelixis_Logo.jpg)
![](https://mms.businesswire.com/media/20240507174596/en/1679909/5/Exelixis_Logo_RGB_2023.jpg)
![](https://mms.businesswire.com/media/20240430821563/en/1679909/5/Exelixis_Logo_RGB_2023.jpg)
Exelixis Announces First Quarter 2024 Financial Results and Provides Corporate Update
April 30, 2024
From Exelixis, Inc.
Via Business Wire
Tickers
EXEL
![](https://mms.businesswire.com/media/20240416694147/en/1679909/5/Exelixis_Logo_RGB_2023.jpg)
![](https://mms.businesswire.com/media/20240227523074/en/1679909/5/Exelixis_Logo_RGB_2023.jpg)
![](https://mms.businesswire.com/media/20240206885107/en/1679909/5/Exelixis_Logo_RGB_2023.jpg)
Exelixis Announces Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Corporate Update
February 06, 2024
From Exelixis, Inc.
Via Business Wire
Tickers
EXEL
![](https://mms.businesswire.com/media/20240201568516/en/1679909/5/Exelixis_Logo_RGB_2023.jpg)
![](https://mms.businesswire.com/media/20240124801283/en/1937209/22/2023_Exelixis_Logo.jpg)
![](https://mms.businesswire.com/media/20240123144117/en/1679909/5/Exelixis_Logo_RGB_2023.jpg)
Exelixis to Release Fourth Quarter and Fiscal Year 2023 Financial Results on Tuesday, February 6, 2024
January 23, 2024
From Exelixis, Inc.
Via Business Wire
Tickers
EXEL
![](https://mms.businesswire.com/media/20240118836827/en/1679909/5/Exelixis_Logo_RGB_2023.jpg)
European Patent Office Rules in Favor of Exelixis on Formulation Patent Covering CABOMETYX® (cabozantinib) Tablets
January 18, 2024
From Exelixis, Inc.
Via Business Wire
Tickers
EXEL
![](https://mms.businesswire.com/media/20240107570082/en/1679909/5/Exelixis_Logo_RGB_2023.jpg)
![](https://mms.businesswire.com/media/20240102006946/en/1679909/5/Exelixis_Logo_RGB_2023.jpg)
Exelixis to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 8, 2024
January 02, 2024
From Exelixis, Inc.
Via Business Wire
Tickers
EXEL
![](https://mms.businesswire.com/media/20231207762237/en/1679909/5/Exelixis_Logo_RGB_2023.jpg)
![](https://mms.businesswire.com/media/20231201184887/en/1937209/22/2023_Exelixis_Logo.jpg)
![](https://mms.businesswire.com/media/20231121271903/en/1679909/5/Exelixis_Logo_RGB_2023.jpg)
Exelixis to Present at the Piper Sandler 35th Annual Healthcare Conference on November 28, 2023
November 21, 2023
From Exelixis, Inc.
Via Business Wire
Tickers
EXEL
![](https://mms.businesswire.com/media/20231106261142/en/1937209/22/2023_Exelixis_Logo.jpg)
![](https://mms.businesswire.com/media/20231101406976/en/1679909/5/Exelixis_Logo_RGB_2023.jpg)
Exelixis Announces Third Quarter 2023 Financial Results and Provides Corporate Update
November 01, 2023
From Exelixis, Inc.
Via Business Wire
Tickers
EXEL
![](https://mms.businesswire.com/media/20231020586023/en/1921769/22/Exelixis_Logo_RGB_2023.jpg)
![](https://mms.businesswire.com/media/20231018651780/en/1679909/5/Exelixis_Logo_RGB_2023.jpg)
Exelixis to Release Third Quarter 2023 Financial Results on Wednesday, November 1, 2023
October 18, 2023
From Exelixis, Inc.
Via Business Wire
Tickers
EXEL
![](https://mms.businesswire.com/media/20230912041846/en/1885889/22/Insilico_logo.jpg)
![](https://mms.businesswire.com/media/20230823099737/en/1874140/22/Exelixis_Logo_RGB_2023.jpg)
![](https://mms.businesswire.com/media/20230823351775/en/1679909/5/Exelixis_Logo_RGB_2023.jpg)
![](https://mms.businesswire.com/media/20230820936777/en/1870961/22/Exelixis_Logo_RGB_2023.jpg)
![](https://mms.businesswire.com/media/20230801307436/en/1679909/5/Exelixis_Logo_RGB_2023.jpg)
Exelixis Announces Second Quarter 2023 Financial Results and Provides Corporate Update
August 01, 2023
From Exelixis, Inc.
Via Business Wire
Tickers
EXEL
![](https://mms.businesswire.com/media/20230721235791/en/1847444/22/Exelixis_Logo_RGB_2023.jpg)
![](https://mms.businesswire.com/media/20230718950128/en/1679909/5/Exelixis_Logo_RGB_2023.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.